Novo CEO pressed by Senate to cut costs of being overweight, diabetic issues medication CEO Lars Fruergaard Jørgensen explained to lawmakers the corporation would look at new talks with insurers in regards to the listing prices of Wegovy and copyright if they pledge to maintain the medicines on their formularies. https://archerpgwmd.boyblogguide.com/29955122/healthcare-news-an-overview